Subject of the case
Operative part
Subject of the case
Re:
ACTION brought against the decision of the First Board of Appeal of OHIM of 7 March 2007 (Case R 1123/2006-1) concerning invalidity proceedings between, initially, Celltech Pharma GmbH & Co. KG and, subsequently, Hennig Arzneimittel GmbH & Co. KG and Longevity Health Products, Inc.
Information relating to the case
>lt>22
Operative part
Operative part
1. The action is dismissed.
2. Longevity Health Products, Inc. is ordered to pay the costs.